- Home
- MSGY vs CASI Comparison
MSGY vs CASI Comparison
Compare MSGY & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGY
- CASI
- Stock Information
- Founded
- MSGY 2018
- CASI 1991
- Country
- MSGY Hong Kong
- CASI China
- Employees
- MSGY N/A
- CASI N/A
- Industry
- MSGY
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- MSGY
- CASI Health Care
- Exchange
- MSGY Nasdaq
- CASI Nasdaq
- Market Cap
- MSGY 24.0M
- CASI 24.9M
- IPO Year
- MSGY 2025
- CASI 1996
- Fundamental
- Price
- MSGY $1.62
- CASI $1.67
- Analyst Decision
- MSGY
- CASI Strong Buy
- Analyst Count
- MSGY 0
- CASI 1
- Target Price
- MSGY N/A
- CASI $4.00
- AVG Volume (30 Days)
- MSGY 691.5K
- CASI 207.2K
- Earning Date
- MSGY 11-13-2025
- CASI 11-13-2025
- Dividend Yield
- MSGY N/A
- CASI N/A
- EPS Growth
- MSGY N/A
- CASI N/A
- EPS
- MSGY 0.10
- CASI N/A
- Revenue
- MSGY $23,318,482.00
- CASI $31,564,000.00
- Revenue This Year
- MSGY N/A
- CASI N/A
- Revenue Next Year
- MSGY N/A
- CASI N/A
- P/E Ratio
- MSGY $15.61
- CASI N/A
- Revenue Growth
- MSGY 13.04
- CASI 36.64
- 52 Week Low
- MSGY $1.41
- CASI $1.09
- 52 Week High
- MSGY $22.20
- CASI $6.50
- Technical
- Relative Strength Index (RSI)
- MSGY N/A
- CASI 43.61
- Support Level
- MSGY N/A
- CASI $1.60
- Resistance Level
- MSGY N/A
- CASI $1.89
- Average True Range (ATR)
- MSGY 0.00
- CASI 0.15
- MACD
- MSGY 0.00
- CASI -0.02
- Stochastic Oscillator
- MSGY 0.00
- CASI 12.26
About MSGY Masonglory Limited Ordinary Shares
Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.